T1	Person 0 27	Liver Transplant Recipients
T2	Procedure 42 64	liver transplantations
T3	Temporal 65 108	for at least 6+1 months prior to enrollment
T4	Reference_point 98 108	enrollment
R1	Has_index Arg1:T3 Arg2:T4	
R2	Has_temporal Arg1:T2 Arg2:T3	
T5	Person 110 137	Liver Transplant Recipients
T6	Negation 143 145	no
T7	Qualifier 146 151	acute
T8	Condition 152 170	rejection episodes
R3	Has_qualifier Arg1:T8 Arg2:T7	
R4	Has_negation Arg1:T8 Arg2:T6	
T9	Temporal 171 210	within 3 months prior to the enrollment
T10	Reference_point 196 210	the enrollment
R5	Has_index Arg1:T9 Arg2:T10	
T11	Condition 219 236	clinically stable
R6	Has_temporal Arg1:T8 Arg2:T9	
T12	Person 238 265	Liver Transplant Recipients
T14	Multiplier 289 300	twice-daily
T15	Drug 312 327	tacrolimus(TAC)
T16	Drug 333 348	everolimus(EVR)
T17	Measurement 353 356;365 378	TAC trough levels
T18	Measurement 361 378	EVR trough levels
T19	Scope 312 348	tacrolimus(TAC) plus everolimus(EVR)
R7	Has_multiplier Arg1:T19 Arg2:T14	
T13	Value 391 413	within targeted ranges
T20	Temporal 414 454	for at least 6 weeks prior to enrollment
T21	Reference_point 444 454	enrollment
R8	Has_index Arg1:T20 Arg2:T21	
T22	Scope 353 378	TAC and EVR trough levels
R9	Has_value Arg1:T22 Arg2:T13	
R10	Has_temporal Arg1:T22 Arg2:T20	
T23	Observation 464 488	written informed consent
T24	Temporal 489 507	prior to inclusion
T25	Reference_point 498 507	inclusion
R11	Has_index Arg1:T24 Arg2:T25	
R12	Has_temporal Arg1:T23 Arg2:T24	
T26	Person 510 537	Liver transplant recipients
T27	Person 561 564	age
T28	Value 546 557	18-65 years
R13	Has_value Arg1:T27 Arg2:T28	
T29	Procedure 570 594	primary liver transplant
T30	Measurement 596 617	Allograft functioning
T31	Value 624 640	acceptable level
T32	Measurement 659 662	AST
T33	Measurement 664 667	ALT
T34	Measurement 669 684	Total Bilirubin
T35	Value 692 704	=3 times ULN
T36	Temporal 705 724	prior to enrollment
T37	Scope 659 684	AST, ALT, Total Bilirubin
R14	Has_value Arg1:T37 Arg2:T35	
R16	Has_value Arg1:T30 Arg2:T31	
T38	Scope 596 640	Allograft functioning at an acceptable level
T39	Scope 659 704	AST, ALT, Total Bilirubin levels =3 times ULN
R15	Subsumes Arg1:T38 Arg2:T37	
R17	Has_temporal Arg1:T38 Arg2:T36	
T40	Measurement 739 748	MDRD eGFR
T41	Value 749 767	= 30 mL/min/1.73m2
R18	Has_value Arg1:T40 Arg2:T41	
